|
Delayed
Bombay S.E.
11:35:52 06/11/2026 +03
|
5-day change | 1st Jan Change | ||
| 448.05 INR | +0.84% |
|
+2.83% | +8.79% |
| 11-04 | Aarti Drugs Limited, Q2 2027 Earnings Call, Nov 04, 2026 | |
| 11-03 | Aarti Drugs Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2026 | CI |
| Market Cap | 40.55B 429M 382M 350M 319M 600M 617M 4.2B 1.68B 21.48B 1.61B 1.58B 67.77B | P/E 2027 * |
-
| P/E 2028 * | 15.9x |
|---|---|---|---|---|---|
| Enterprise Value | 40.55B 429M 382M 350M 319M 600M 617M 4.2B 1.68B 21.48B 1.61B 1.58B 67.77B | EV / Sales 2027 * |
1.38x | EV / Sales 2028 * | 1.24x |
| Free-Float |
40.44% | Yield 2027 * |
1.33% | Yield 2028 * | 1.58% |
| Markets | Quality | ||
|---|---|---|---|
Bombay S.E.
| AARTIDRUGS | Delayed | |
NSE India S.E.
| AARTIDRUGS | Delayed |
Last Transcript: Aarti Drugs Limited
| 28/12/22 | Aarti Drugs : Loss of Share Certificates | PU |
| 10/07/22 | Aarti Drugs : Newspaper Advertisements | PU |
| 1 day | +0.84% | ||
| 1 week | +2.83% | ||
| Current month | +2.83% | ||
| 1 month | +4.57% | ||
| 3 months | +9.03% | ||
| 6 months | +12.49% | ||
| Current year | +8.79% |
| 1 week | 434.8 |  | 500 |
| 1 month | 369 | | 500 |
| Current year | 318.6 | | 500 |
| 1 year | 318.6 | | 533.6 |
| 3 years | 312.5 | | 634.9 |
| 5 years | 310.8 | | 645 |
| 10 years | 104.82 | | 1,025 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 80 | - | |
| Chief Tech/Sci/R&D Officer | - | - | |
| Compliance Officer | - | 23/04/2019 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 63 | 01/06/2007 | |
| Chairman | 80 | - | |
| Director/Board Member | 64 | 02/01/1987 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.84% | +2.83% | -8.40% | -5.31% | 429M | |
| -3.76% | -0.65% | +47.41% | +140.35% | 1,216B | |
| -1.45% | -1.05% | +46.41% | +79.94% | 656B | |
| -2.24% | -0.88% | +32.97% | +103.82% | 509B | |
| -1.67% | -4.71% | +44.95% | +62.09% | 384B | |
| -2.27% | +0.42% | +74.12% | +42.14% | 362B | |
| -2.21% | -2.21% | +28.36% | +55.29% | 311B | |
| -2.86% | -2.48% | +6.08% | +32.48% | 293B | |
| -3.80% | -0.10% | +43.90% | +70.56% | 249B | |
| -3.96% | +1.18% | +36.70% | +105.38% | 208B | |
| Average | -2.34% | +0.46% | +35.25% | +68.67% | 418.82B | |
| Weighted average by Cap. | -2.73% | +0.03% | +42.53% | +91.02% |
| 2027 * | 2028 * | |
|---|---|---|
| Net sales | 29.45B 312M 278M 254M 231M 436M 448M 3.05B 1.22B 15.6B 1.17B 1.14B 49.22B | 32.69B 346M 308M 282M 257M 484M 497M 3.39B 1.35B 17.31B 1.3B 1.27B 54.62B |
| Net income | 2.15B 22.77M 20.29M 18.56M 16.9M 31.86M 32.72M 223M 89.16M 1.14B 85.48M 83.64M 3.6B | 2.55B 26.94M 24.01M 21.96M 20M 37.7M 38.71M 264M 105M 1.35B 101M 98.95M 4.25B |
| Net Debt | - | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 06/11/26 | ₹448.05 | +0.84% | 12,680 |
| 05/11/26 | ₹444.30 | -2.23% | 23,113 |
| 04/11/26 | ₹454.45 | -2.39% | 171,233 |
| 03/11/26 | ₹465.60 | +2.60% | 54,012 |
| 02/11/26 | ₹453.80 | +4.15% | 35,290 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Annual profits - Rate of surprise
- Stock Market
- Stocks
- AARTIDRUGS Stock
Select your edition
All financial news and data tailored to specific country editions
